SXTP - Kapitalisasi marang volume dodolan 60 Degrees Pharmaceuticals Inc.

60 Degrees Pharmaceuticals (SXTP) commercializes treatments for tropical infections to protect military personnel and tourists. The price-to-sales ratio trend on the GURU.Markets chart shows that the value is holding at 1.10. Government contracts and clinics ensure stable demand. The business relies on a high-leverage patent model, utilizing distributors to scale without increasing headcount.

60 Degrees Pharmaceuticals (SXTP): Rasio rega marang pendapatan saka 03.04.2024 nganti 13.11.2026

Rincian metrik lan analitis perusahaan 60 Degrees Pharmaceuticals (SXTP)

- rega pasar lan target rega analis:

Kutipan saham 60degreespharma.com|SXTP - Target konsensus

- statistik kapitalisasi pasar:

Nilai pasar 60 Degrees Pharma|SXTP - Nilai Perusahaan

- informasi kapitalisasi buku:

Aset Bersih saben Saham 60 Degrees Pharmaceuticals|SXTP - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku 60degreespharma.com|SXTP - Aset Agregat Perusahaan

- statistik kawajiban utang lan likuiditas:

Rasio Utang marang Ekuitas 60 Degrees Pharmaceuticals|SXTP - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal 60degreespharma.com|SXTP - Gunggung tanggungan utang perusahaan|Utang marang modal buku 60 Degrees Pharma|SXTP - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan 60 Degrees Pharmaceuticals|Rasio likuiditas darurat 60degreespharma.com

- data bathi resik lan rasio valuasi:

SXTP - Bathi resik|Bathi resik sing dikarepake 60 Degrees Pharmaceuticals|SXTP - Pangali P/E|Pangali forward rega marang bathi 60degreespharma.com|SXTP - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan 60 Degrees Pharma|SXTP - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan 60 Degrees Pharmaceuticals|SXTP - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan 60degreespharma.com|SXTP - Wutah bathi saben saham ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep 60 Degrees Pharmaceuticals

- data total pendapatan lan volume dodolan:

SXTP - Dodolan perusahaan|Pendapatan mangsa ngarep perusahaan 60degreespharma.com|SXTP - Rasio rega marang pendapatan|Rega mangsa ngarep marang pendapatan 60 Degrees Pharma

Analisis wiwitan perusahaan:60 Degrees Pharmaceuticals Inc.

Produk sing diprodhuksi 60 Degrees Pharmaceuticals Inc.

Due to its monopoly position in the antimalarial segment and the inelastic demand for Arakoda, 60 Degrees Pharmaceuticals (SXTP) possesses significant pricing power. This enterprise value-to-revenue multiple correlates market capitalization with annual turnover, allowing investors to track business valuation phases in real-time and promptly identify correction risks during extreme metric deviations.

Karo sapa 60 Degrees Pharmaceuticals saingan

Kapitalisasi marang pendapatan summittxinc.com SMMT|Moderna - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan PCVX (Vaxcyte Inc)|Tarsus Pharma - Multiplikator P/S|Koefisien rega marang pendapatan CorMedix Therapeutics CRMD|Seres Therapeutics (MCRB) - Rasio rega marang pendapatan|Rega marang dodolan sperotherapeutics.com (SPRO)|Rasio rega marang pendapatan SCYNEXIS Inc|Rasio kapitalisasi marang pendapatan ANTX (AN2 Bio)|Rasio rega marang pendapatan PolyPid Ltd. (PYPD)|Koefisien rega marang pendapatan YS Biopharma Co., Ltd.|Iterum Therapeutics (ITRM) - Rasio rega marang dodolan|Kapitalisasi marang volume dodolan PHGE (BiomX Inc)|SNGX: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan OGEN (oragenics.com)|OPGN: Multiplikator P/S